Evidence map›Paper›PMID 35934198›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 2020.

Anju Murayama, Kenji Nakano, Sae Kamamoto, Masaya Sato, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki

Abstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anju MurayamaMedical Governance Research Institute, Minato-ku, Tokyo, Japan; Tohoku University School of Medicine, Sendai City, Miyagi, Japan. Electronic address: ange21tera@gmail.com.
Kenji NakanoTohoku University School of Medicine, Sendai City, Miyagi, Japan.
Sae KamamotoMedical Governance Research Institute, Minato-ku, Tokyo, Japan; Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka, Japan.
Masaya SatoMedical Governance Research Institute, Minato-ku, Tokyo, Japan; School of Engineering, Hokkaido University, Sapporo City, Hokkaido, Japan.
Hiroaki SaitoMedical Governance Research Institute, Minato-ku, Tokyo, Japan; Department of Internal Medicine, Soma Central Hospital, Soma City, Fukushima, Japan.
Tetsuya TanimotoMedical Governance Research Institute, Minato-ku, Tokyo, Japan; Department of Internal Medicine, Navitas Clinic Tachikawa, Tachikawa, Tokyo, Japan.
Akihiko OzakiMedical Governance Research Institute, Minato-ku, Tokyo, Japan; Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City, Fukushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the trend in nonresearch payments made by the industries to the infectious disease physicians in the United States since the launch of the Open Payments Database and during the COVID-19 pandemic.

methodsDescriptive analysis was performed for the nonresearch payments made to all infectious disease physicians listed in the Open Payments Database between 2014 and 2020. Using the generalized estimating equation models with panel data of monthly and yearly payment per physician, the payment trend since the inception of the Open Payments Database and during the early stage of the COVID-19 pandemic were evaluated.

resultsA total of 7901 (81.5%) infectious disease physicians received $156 837 987 in nonresearch payments between 2014 and 2020. Median annual payments were $197 to $220. Monthly nonresearch per-physician payments and number of physicians with payments rapidly decreased by 58.6% (95% CI: 49.7%‒65.9%, p < 0.001) and by 54.4% (95% CI: 52.7%‒56.1%, p < 0.001) at the beginning of the COVID-19 pandemic, respectively. However, the per-physician payments and number of physicians with payments slightly increased every month right after onset of the pandemic. Both per-physician payments and the number of physicians with payments decreased by 2.6% (95% CI: 0.45‒4.7, p 0.018) and 2.0% (95% CI: 1.6%‒2.4%, p < 0.001) since the inception of the Open Payments Database, respectively. DISCUSSION: The nonresearch payments and number of infectious disease physicians accepting payments had decreased since the inception of the Open Payments Database. Furthermore, the non-research payments to infectious disease physicians suddenly decreased by more than half due to the COVID-19 pandemic.

Indexed as

Communicable DiseasesCOVID-19PhysiciansConflict of InterestDatabases, FactualHumansIndustryPandemicsUnited StatesCOVID-19Health policyIndustry paymentsInfectious disease physicianOpen paymentsPhysician paymentPhysician payments sunshine actSARS-CoV-2United States

Identifiers

PMID35934198
PMCPMC9352402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.